| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cbp-501 | mapk-activated protein kinase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Mesothelioma[MeSHID:D008654] |
5.3 | phase 1/2 | unknown |
| cbp-501 | microtubule affinity regulating kinase 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Mesothelioma[MeSHID:D008654] |
1.52 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||